DVDenis O. Vladimirov

Denis O. Vladimirov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Denis O. Vladimirov has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Electrocardiographic Signs of Myocardial Depolarization Disorders in Newborns Conceived by in Vitro Fertilization and the Possibilities of its Management

    by Evgeniya N. Tyagusheva, Larisa A. Balykova, Elena I. Naumenko, Tatyana I. Vlasova, Tatyana S. Tumaeva, Denis O. Vladimirov, Olga E. Tishkova, Е. Н. Тягушева, Л. А. Балыкова, Е. И. Науменко, et al.

    Background . Recently, a significant increase in the use of Ancillary Assisted Reproductive Technologies (ART) is noted. Meanwhile, the electrophysiological state of the myocardium, including the risk of cardiac rhythm disorders (CRD), in newborns after in vitro fertilization (IVF) remains poorly understood. No comprehensive assessments of the parameters of a standard electrocardiogram (ECG) is available, as well as approaches to their treatment in the early neonatal period in this category of patients. Objective . The aim of the study is to research the electrocardiographic effects of myocardial depolarization disorders in newborns conceived with IVF and to evaluate the effectiveness of Cytoflavin in treatment of the detected disorders in premature infants with cerebral ischemia (CI). Methods . The study design included 2 stages. At the first stage, a single-center, nonconcurrent, cross-sectional comparative cohort study was conducted, which included 580 newborns divided into 2 groups: the main group (children after IVF, n = 206) and the comparison group (children from spontaneous pregnancy, n = 374). The groups were stratified by fetal age (35–37 and 38-40 weeks), and the presence of CI, grade I–II. On the 3rd day of life, all children underwent a standard ECG with an analysis of rhythm parameters, conduction, and markers of depolarization disorders. At the second stage, an open comparative randomized study of the efficacy of Cytoflavin (2 ml/kg/day) was conducted in 60 premature infants with CI. The dynamics of rhythm disturbances was assessed on the 5th day after therapy. Results . Atrial rhythm (8.3% vs. 2.5%, p = 0.003) and supraventricular extrasystole (15.5% vs. 7.4%, p = 0.004) were more frequently reported in newborns conceived by IVF. Specific changes in depolarization parameters have been identified: a decrease in the amplitude and duration of the P wave, a shortening of the PQ interval, and an elongation of the QRS complex. The most pronounced violations of intraventricular conduction were observed in premature infants with СI of the main group. Multifactorial analysis confirmed that the method of conception (IVF) is an independent risk factor for depolarization disorders (OR = 1.58; 95% CI 1.05–2.38; p = 0.028) along with the presence of CI (OR = 2.41; 95% CI 1.60–3.64; p < 0.001). The administration of Cytoflavin at the basic therapy was accompanied by a statistically significant decrease in the frequency of sinus bradycardia and supraventricular extrasystole by day 5 of treatment (p < 0.05) both in the group of children after IVF and in children from spontaneous pregnancy. Conclusion . Newborns conceived using IVF form an increased risk group for the development of myocardial depolarization disorders on the 3rd day of life. The greatest risk is observed when the IVF factor is combined with prematurity and CI. The use of Cytoflavin in premature infants with CI demonstrates a positive effect in correcting the identified CRD, which justifies the possibility of its use in this category of patients.

  • Open Access

    Electrical instability of the myocardium in children of different ages: diagnosis, prognostic significance and principles of correction (literature review)

    by Larisa A. Balykova, Denis O. Vladimirov, Evgenia N. Tyagusheva, Marina V. Shirmankina, Anna V. Krasnopolskaya, Elena I. Naumenko

    Varying degrees of risk of life-threatening conditions. Today, the problem of diagnosis and clinical interpretation of EIM in newborns is particularly acute due to anatomical and physiological features and comorbid conditions, as well as in children and adolescents with organic heart diseases. Studying the heterogeneity of electrocardiographic (ECG) morphology of cardiac cycles may have prognostic value for the prevention of arrhythmic events. The article provides an overview of modern scientific data on the signs of EIM in children, including the newborn period, formed into two large groups: depolarization and repolarization disorders. ECG criteria for EIM in children of different ages with congenital (primary) electrical diseases and acquired conditions, including COVID-19, are discussed. The methods of medical correction of ENM in newborns and children in subsequent age periods are highlighted. The totality of the data presented dictates the need for further study of the prognostic significance of EIM and methods of its correction.


  • Open Access

    Electrical Instability of the Myocardium in Children and Adolescents

    by Larisa A. Balykova, Marina V. Shirmankina, Stanislav A. Ivyanskiy, Anna V. Krasnopolskaya, Denis O. Vladimirov, Tatyana S. Shablinova, Evgenia N. Tyagusheva, Тягушева Евгения Николаевна

    Currently, there is no doubt that the problem of electrical instability of the myocardium in pediatric cardiology is relevant. The determination of various indicators of electrical instability of the myocardium, which are predictors of life-threatening rhythm disorders and sudden cardiac death, presents an underdeveloped task not only for functional diagnostics specialists, but also for pediatricians, neonatologists, pediatric cardiologists and doctors of other specialties. Non-invasive research methods such as electrocardiography (ECG), Holter ECG monitoring (HM ECG), available in almost all pediatric treatment and prevention institutions, are quite informative in terms of detecting electrophysiological heterogeneity of the myocardium as a predictor of sudden cardiac death, which is especially important in children at risk, as well as young athletes. Thus, the determination of indicators of electrical instability of the myocardium is of great interest, it is a promising direction in modern clinical practice, allowing to predict the risk of developing fatal arrhythmias in children and adolescents.


  • CARDIOVASCULAR SYSTEM IN NEWBORNS BORN TO MOTHERS WHO HAD A NEW CORONAVIRUS INFECTION DURING PREGNANCY

    by D.O. Vladimirov, L.A. Balykova, M.V. Shirmankina, A.V. Kudashova, I.S. Nazarova, Penza Federal Center For Cardiovascular Surgery Of The Ministry Of Healthcare Of Russia, N.R. Belkina, Saransk Mordovian Republican Children’s Clinical Hospital, O.M. Soldatov

    Cardiac manifestations in the acute phase and complications of COVID-19 in children, especially newborns, have not been sufficiently studied as yet. The purpose of this research was to determine the nature of damage to the cardiovascular system (CVS) in newborns from mothers who had a new coronavirus infection at different stages of pregnancy and who were infected after birth. Materials and methods used: a single-center observational comparative study with elements of retrospective analysis. The 3 groups of full-term newborns of 37 each were formed as follows: the main group 1 (A) of newborns from mothers who had a laboratory-confirmed new coronavirus infection in the 1st to 2nd trimesters of pregnancy; the comparison group 2 (B) of newborns with a laboratory-confirmed new coronavirus infection from mothers who had COVID-19 in the peripartum period; and the control group 3 (C) of practically healthy newborns. The frequency of various types of CVS lesions (myocarditis, rhythm and conduction disorders, perinatal CVS lesions) as well as the frequency of occurrence of signs of electrophysiological myocardial instability, hemodynamic disorders and increased levels of cardiac-specific enzymes were assessed. Results: newborns from mothers who suffered a new coronavirus infection during pregnancy are more likely than newborns from physiologically healthy pregnancy and childbirth to develop cardiac problems (heart failure (p=0.025), cardiac arrhythmias (p<0.001), specified congenital anomalies of the cardiac septum (p1-3<0.001), other specified congenital heart anomalies (p1-3=0.032) and other cardiovascular disorders that arose in the perinatal period (p<0.001)), in particular, maladaptive disorders of the cardiovascular system with signs of electrical instability of the myocardium, dilation of the heart cavities and increased levels of cardiac-specific enzymes, which required the exclusion of myocarditis. Conclusion: the identified changes in the cardiovascular system dictate the need for monitoring of newborns from mothers with COVID-19 with dynamic CVS assessment.


  • CARDIOVASCULAR SYSTEM DAMAGE IN CHILDREN WITH COVID-19

    by L.A. Balykova, D.O. Vladimirov, A.V. Krasnopolskaya, O.M. Soldatov, Saransk Mordovian Republican Children’s Clinical Hospital, N.V. Ivyanskaya, N.V. Shchekina

    Coronavirus infection poses a particular danger in relation to decompensation of existing chronic diseases and specific damage to the cardiovascular system (CVS) both during an acute infection and during convalescence. Objective of the study: to summarize current knowledge about the potential involvement of CVS in the development and progression of acute COVID-19 infection and multisystem inflammatory syndrome (MIS) in children and to form an sense of the predictive value, diagnostic tactics and treatment of cardiac anomalies during the coronavirus pandemic. A search was performed in MEDLINE, PubMed, e-library using the search terms «cardiovascular disease in COVID-19/MIS in children», «congenital heart disease/pulmonary hypertension/prolonged QT interval and COVID-19 in children» to identify articles published from April 1, 2020 to May 1, 2021. A literature review indicates that cardiac disorders associated with the new coronavirus infection in children, in the vast majority of cases, developed during MIS, which manifests itself in the form of febrile fever, external signs of Kawasaki disease, hyperinflammatory state and multi-organ damage with an emphasis on CVS. Cardiovascular symptoms occur in the vast majority of children with MIS, and in more than half of the patients – by the type of myocardial dysfunction and/or shock, somewhat less often – in the form of ECG changes, pericardial effusion, сoronary artery ectasia. Against the background of treatment with steroids, intravenous human immunoglobulin (IVIG) and biologic drugs in combination with inotropic support in almost all children, the morphofunctional characteristics of CVS are restored to normal or subnormal levels in a few days. The need for extracorporeal membrane oxygenation and lethal cases are rare. The possibility of developing myocarditis (including fatal), pulmonary hypertension and cardiac arrhythmias associated with COVID-19 in pediatric patients with discussion of possible pathophysiological mechanisms was also described. Long-term observation of this category of persons is necessary due to the uncertain prognosis and the risk of progression of cardiac manifestations. An early comprehensive diagnosis of cardiac disorders and monitoring of the identified changes in children with MIS and acute coronavirus infection are needed.


  • Влияние амиодарона на тиреоидный статус у детей

    by Е. С. Самошкина, Л. А. Балыкова, К. А. Варлашина, Денис Олегович Владимиров, И. С. Назарова, А. В. Краснопольская, О. М. Солдатов

    Исследован тиреоидный статус у 45 детей на протяжении 1 года применения амиодарона. У большинства пациентов отмечены индивидуальные колебания уровня гормонов и увеличение объема щитовидной железы, но клинически значимые тиреопатии выявлены в 8,8 % случаев. У 2 детей (4,4 %) диагностирован гипотиреоз, у 2 % — тиреотоксикоз. Описан клинический случай развития амиодарон-индуцированного тиреотоксикоза. Продемонстрированы сложности диагностики и возможность спонтанной ремиссии данного состояния. Полученные результаты подтверждают относительно низкую вероятность развития амиодарон-индуцированных тиреопатий в педиатрической практике.